Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Debt / NOTE 3/0
-
Number of holders
-
47
-
Total 13F principal, excl. options
-
495,645,344
-
Principal change
-
+23,760,174
-
Total reported value, excl. options
-
$442,147,642
-
Value change
-
+$20,282,323
-
Number of buys
-
14
-
Number of sells
-
-23
-
Price
-
$0.8905
Significant Holders of HAEMONETICS CORP MASS - NOTE 3/0 as of Q4 2023
55 filings reported holding 405024AB6 - HAEMONETICS CORP MASS - NOTE 3/0 as of Q4 2023.
HAEMONETICS CORP MASS - NOTE 3/0 has 47 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $495,645,344 of principal
.
Largest 10 bondholders include LINDEN ADVISORS LP ($82,021,000 of principal), FRANKLIN RESOURCES INC ($50,000,000 of principal), READYSTATE ASSET MANAGEMENT LP ($32,700,000 of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($29,964,000 of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($29,491,000 of principal), MACKAY SHIELDS LLC ($28,318,000 of principal), DeepCurrents Investment Group LLC ($26,121,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($25,207,000 of principal), AVIVA PLC ($23,080,000 of principal), and Aequim Alternative Investments LP ($20,500,000 of principal).
This table shows the top 47 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.